- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 5/12 - Peptides cycliques
Détention brevets de la classe C07K 5/12
Brevets de cette classe: 347
Historique des publications depuis 10 ans
|
29
|
26
|
18
|
27
|
26
|
21
|
16
|
19
|
13
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| University of Florida Research Foundation, Inc. | 4183 |
13 |
| Suntory Holdings Limited | 2196 |
9 |
| The University of British Columbia | 1546 |
8 |
| Novmetapharma Co., Ltd. | 82 |
8 |
| Centre National de La Recherche Scientifique | 11042 |
6 |
| University of Kansas | 923 |
6 |
| The Regents of the University of California | 20790 |
5 |
| Enanta Pharmaceuticals, Inc. | 421 |
5 |
| Merck Sharp & Dohme LLC | 3737 |
5 |
| Bristol-myers Squibb Company | 4747 |
4 |
| Merck & Co., Inc. | 143 |
4 |
| Massachusetts Institute of Technology | 10259 |
4 |
| The Regents of the University of Michigan | 5002 |
4 |
| Celgene Corporation | 1413 |
4 |
| Children's Medical Center Corporation | 1959 |
4 |
| Chugai Seiyaku Kabushiki Kaisha | 1421 |
4 |
| Istituto di Ricerche di Biologia Molecolare P. Angeletti S.p.A. | 44 |
4 |
| Mimetogen Pharmaceuticals, Inc. | 17 |
4 |
| The Texas a & M University System | 1892 |
4 |
| Yeda Research and Development Co. Ltd. | 1381 |
4 |
| Autres propriétaires | 238 |